Brief: Eurobio Scientific Receives USD 430,000 Milestone Payment From Allergan
Oct 6 (Reuters) - EUROBIO SCIENTIFIC SA ALERS.PA :
* EUROBIO SCIENTIFIC RECEIVES A $430,000 MILESTONE PAYMENT
FROM
ALLERGAN
* TRANSITION TO CLINICAL STAGE OF A MOLECULE DERIVED FROM
FORMER
COLLABORATION
* MILESTONE PAYMENT OF US $ 430,000 AS PART OF AN IND
SUBMISSION
TO US FDA FOR TRANSITION TO CLINICAL PHASE OF AGN-231868
MOLECULE IN TREATMENT OF DRY EYE SYNDROME
Source text for Eikon: ID:nNDL33czzC
Further company coverage: ALERS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Eurobio Scientific SA
See all newsBrief: Eurobio Scientific EB Development Files Public Offer For Shares
Brief: Eurobio Scientific Says At End Of June 2024, Recorded Revenues Of 73.4 Mln Euros, Compared With 59.1 Mln Euros A Year Ago
Brief: Eurobio Scientific FY Core Business Revenues Up At EUR 130 Mln
Brief: Eurobio Scientific Cancels 694,300 Treasury Shares, Representing Around 6.34% Of Share Capital
Brief: Eurobio Scientific H1 Ebitda Up To EUR 13.4 Million